Apyx Medical Corp Other Executive Compensation Disclosures
Every other executive-compensation XBRL fact the company filed (policies, award timing, footnotes, adjustments), newest first. Long text is shortened; the filing has the full text.
- 2024-11-08: Disclosure Rule10b51Arr Adopted; Period 2024-07-01..2024-09-30; Value No.
- 2024-11-08: Disclosure Non Rule10b51Arr Adopted; Period 2024-07-01..2024-09-30; Value No.
- 2024-11-08: Disclosure Rule10b51Arr Terminated; Period 2024-07-01..2024-09-30; Value No.
- 2024-11-08: Disclosure Non Rule10b51Arr Terminated; Period 2024-07-01..2024-09-30; Value No.
| Filed | Disclosure | Qualifiers | Period | Value |
|---|---|---|---|---|
| 2024-11-08 10-Q | Rule10b51Arr Adopted | 2024-07-01..2024-09-30 | No | |
| 2024-11-08 10-Q | Non Rule10b51Arr Adopted | 2024-07-01..2024-09-30 | No | |
| 2024-11-08 10-Q | Rule10b51Arr Terminated | 2024-07-01..2024-09-30 | No | |
| 2024-11-08 10-Q | Non Rule10b51Arr Terminated | 2024-07-01..2024-09-30 | No | |
| 2024-11-08 10-Q | Material Terms Of Trading Arrangement | 2024-01-01..2024-09-30 | ITEM 5. Other Information None. | |
| 2024-06-25 DEF 14A | Named Executive Officers Footnote | 2023-01-01..2023-12-31 | This section is included to comply with the provisions of Item 402(v) of Regulation S-K. For a more comprehensive analysis of our compensation philosophy please see the General Compensation Philosophy section of this filing. In the table and footnotes below, “PEO” refers to our principal executive o… | |
| 2024-06-25 DEF 14A | Pay versus Performance Table | 2023-01-01..2023-12-31 | Pay versus performance table (a) (b) (c) (d) (e) (f) (h) Year Summary compensation table total for PEO Compensation actually paid to PEO Average summary compensation table total for non-PEO NEOs (1) Average compensation actually paid to non-PEO NEOs (1) Value of initial fixed $100 investment based o… | |
| 2024-06-25 DEF 14A | Named Executive Officers Footnote | 2022-01-01..2022-12-31 | Moshe Citronowicz, Todd Hornsby and Tara Semb are the non-PEO named executive officers for the 2022 and 2021 years presented. | |
| 2024-06-25 DEF 14A | Named Executive Officers Footnote | 2021-01-01..2021-12-31 | Moshe Citronowicz, Todd Hornsby and Tara Semb are the non-PEO named executive officers for the 2022 and 2021 years presented | |
| 2024-06-25 DEF 14A | Adjustment To Non PEO NEO Compensation Footnote | 2023-01-01..2023-12-31 | The following table summarizes the adjustments from summary table total compensation to compensation actually paid: PEO Non-PEO NEOs 2023 2022 2021 2023 2022 2021 Summary compensation table total compensation $ 1,261,470 $ 2,170,236 $ 1,594,394 $ 769,679 $ 974,614 $ 776,134 Grant date fair value of … | |
| 2024-06-25 DEF 14A | Adjustment To PEO Compensation Footnote | 2023-01-01..2023-12-31 | The following table summarizes the adjustments from summary table total compensation to compensation actually paid: PEO Non-PEO NEOs 2023 2022 2021 2023 2022 2021 Summary compensation table total compensation $ 1,261,470 $ 2,170,236 $ 1,594,394 $ 769,679 $ 974,614 $ 776,134 Grant date fair value of … | |
| 2024-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsGrantedDuringTheYear; ExecutiveCategory: Peo | 2023-01-01..2023-12-31 | -$448.33K |
| 2024-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsGrantedDuringTheYear; ExecutiveCategory: Peo | 2022-01-01..2022-12-31 | -$1.66M |
| 2024-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsGrantedDuringTheYear; ExecutiveCategory: Peo | 2021-01-01..2021-12-31 | -$701.42K |
| 2024-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsGrantedDuringTheYear; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | -$164.82K |
| 2024-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsGrantedDuringTheYear; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | -$612.02K |
| 2024-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsGrantedDuringTheYear; ExecutiveCategory: NonPeoNeo | 2021-01-01..2021-12-31 | -$257.86K |
| 2024-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsGrantedDuringTheYearOutstandingAndUnvested; ExecutiveCategory: Peo | 2023-01-01..2023-12-31 | $493.29K |
| 2024-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsGrantedDuringTheYearOutstandingAndUnvested; ExecutiveCategory: Peo | 2022-01-01..2022-12-31 | $255.11K |
| 2024-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsGrantedDuringTheYearOutstandingAndUnvested; ExecutiveCategory: Peo | 2021-01-01..2021-12-31 | $1.00M |
| 2024-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsGrantedDuringTheYearOutstandingAndUnvested; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | $116.39K |
| 2024-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsGrantedDuringTheYearOutstandingAndUnvested; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | $93.79K |
| 2024-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsGrantedDuringTheYearOutstandingAndUnvested; ExecutiveCategory: NonPeoNeo | 2021-01-01..2021-12-31 | $368.13K |
| 2024-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsGrantedInPriorYearsOutstandingAndUnvested; ExecutiveCategory: Peo | 2023-01-01..2023-12-31 | $65.73K |
| 2024-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsGrantedInPriorYearsOutstandingAndUnvested; ExecutiveCategory: Peo | 2022-01-01..2022-12-31 | -$1.16M |
| 2024-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsGrantedInPriorYearsOutstandingAndUnvested; ExecutiveCategory: Peo | 2021-01-01..2021-12-31 | $1.03M |
| 2024-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsGrantedInPriorYearsOutstandingAndUnvested; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | $15.51K |
| 2024-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsGrantedInPriorYearsOutstandingAndUnvested; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | -$425.08K |
| 2024-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsGrantedInPriorYearsOutstandingAndUnvested; ExecutiveCategory: NonPeoNeo | 2021-01-01..2021-12-31 | $356.31K |
| 2024-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsGrantedInPriorYearsVested; ExecutiveCategory: Peo | 2023-01-01..2023-12-31 | $41.33K |
| 2024-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsGrantedInPriorYearsVested; ExecutiveCategory: Peo | 2022-01-01..2022-12-31 | -$257.93K |
| 2024-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsGrantedInPriorYearsVested; ExecutiveCategory: Peo | 2021-01-01..2021-12-31 | $224.03K |
| 2024-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsGrantedInPriorYearsVested; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | $660.00 |
| 2024-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsGrantedInPriorYearsVested; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | -$86.47K |
| 2024-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsGrantedInPriorYearsVested; ExecutiveCategory: NonPeoNeo | 2021-01-01..2021-12-31 | $140.61K |
| 2024-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsGrantedDuringTheYearVested; ExecutiveCategory: Peo | 2023-01-01..2023-12-31 | $0.00 |
| 2024-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsGrantedDuringTheYearVested; ExecutiveCategory: Peo | 2022-01-01..2022-12-31 | $0.00 |
| 2024-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsGrantedDuringTheYearVested; ExecutiveCategory: Peo | 2021-01-01..2021-12-31 | $0.00 |
| 2024-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsGrantedDuringTheYearVested; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | $8.19K |
| 2024-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsGrantedDuringTheYearVested; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | $0.00 |
| 2024-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsGrantedDuringTheYearVested; ExecutiveCategory: NonPeoNeo | 2021-01-01..2021-12-31 | $0.00 |
| 2024-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsGrantedInPriorYearsForfeited; ExecutiveCategory: Peo | 2023-01-01..2023-12-31 | $0.00 |
| 2024-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsGrantedInPriorYearsForfeited; ExecutiveCategory: Peo | 2022-01-01..2022-12-31 | $0.00 |
| 2024-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsGrantedInPriorYearsForfeited; ExecutiveCategory: Peo | 2021-01-01..2021-12-31 | $0.00 |
| 2024-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsGrantedInPriorYearsForfeited; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | -$11.20K |
| 2024-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsGrantedInPriorYearsForfeited; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | $0.00 |
| 2024-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardsGrantedInPriorYearsForfeited; ExecutiveCategory: NonPeoNeo | 2021-01-01..2021-12-31 | $0.00 |
| 2024-06-25 DEF 14A | Compensation Actually Paid Vs Total Shareholder Return | 2023-01-01..2023-12-31 | The following table presents a comparison of our actual compensation paid to NEOs versus our total stockholder return, net losses: (in thousands except per share data) 2023 2022 2023 vs 2022 Change 2021 2022 vs 2021 Change Total stockholder return (change in stock price) $ 2.62 $ 2.34 12.0 % $ 12.82… | |
| 2024-06-25 DEF 14A | Compensation Actually Paid Vs Net Income | 2023-01-01..2023-12-31 | The following table presents a comparison of our actual compensation paid to NEOs versus our total stockholder return, net losses: (in thousands except per share data) 2023 2022 2023 vs 2022 Change 2021 2022 vs 2021 Change Total stockholder return (change in stock price) $ 2.62 $ 2.34 12.0 % $ 12.82… |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |